Dr. van der Heijde presents results of dual neutralization of Il-17A and F with bimekizumab which may provide a new therapeutic option for patients with AxSpA. Abstract OPO231. #EULAR2019 @RheumNow #spondylitis https://t.co/caOkc47jyn